| Literature DB >> 31378056 |
Eun-Ji Choi1, Yoon Ji Choi2, Sang Won Lee2, Yun-Mi Choi1, Hyun-Su Ri1, Ju Yeon Park1, Soon Ji Park1, Jung-Min Son3, Yoon Sook Lee2.
Abstract
BACKGROUND: There are various reports on the effects of the anesthetic method on neurologic complications. A population-based study was conducted to estimate the effect of anesthetic method on the incidence of postoperative delirium in patients that underwent total hip replacement arthroplasty in South Korea.Entities:
Keywords: Delirium; General anesthesia; Korean National Health Insurance claims data; Regional anesthesia; Total hip replacement arthroplasty
Mesh:
Year: 2019 PMID: 31378056 PMCID: PMC7000278 DOI: 10.4097/kja.19091
Source DB: PubMed Journal: Korean J Anesthesiol ISSN: 2005-6419
Fig. 1.CONSORT flow diagram of this study.
Fig. 2.Patients that underwent total hip replacement arthroplasty according to year.
Fig. 3.(A) Patients that underwent total hip replacement arthroplasty with general anesthesia classified by age and according to year. (B) Patients that underwent total hip replacement arthroplasty with regional anesthesia classified by age and according to year.
Demographic Data of Patients That Underwent Total Hip Replacement Arthroplasty.
| Group GA (n = 9,921) | Group RA (n = 14,458) | P value | |
|---|---|---|---|
| Sex (M/F) | 5,938 (59.85)/3,983 (40.14) | 8,925 (61.73)/5,533 (38.27) | 0.003 |
| Age (yr) | 52.20 ± 11.51 | 53.59 ± 10.83 | < 0.001 |
| < 65 | 8,400 (84.67) | 11,909 (82.37) | |
| 65–75 | 1,513 (15.25) | 2,486 (17.19) | |
| 75–85 | 8 (0.08) | 57 (0.39) | |
| 85 ≤ | 0 | 5 (0.03) | |
| Hypertension | 1,553 (15.65) | 2,257 (15.61) | 0.938 |
| DM | 1,030 (10.38) | 1,538 (10.64) | 0.523 |
| Cardiac disease | 418 (4.21) | 506 (3.50) | 0.004 |
| Myocardiac infarction | 107 (1.08) | 111 (0.77) | < 0.001 |
| Chronic pulmonary disease | 229 (2.31) | 291 (2.01) | 0.975 |
| Dementia | 14 (0.14) | 11 (0.08) | 0.997 |
| Parkinson’s disease | 13 (0.13) | 18 (0.12) | 0.999 |
| Mental and behavioral disorder (mood) | 176 (1.77) | 179 (1.24) | 0.988 |
| Chronic kidney disease | 151 (1.52) | 131 (0.91) | 0.984 |
| Mild liver disease | 1332 (13.43) | 2313 (14.0) | < 0.001 |
| Peripheral vascular disease | 86 (0.87) | 481 (3.33) | < 0.001 |
| Acquired immune deficiency syndrome | 23 (0.23) | 17 (0.12) | < 0.001 |
| Charlson comorbidity index | < 0.001 | ||
| 0 | 6508 (65.60) | 9301 (64.33) | |
| 1 | 2620 (26.41) | 4246 (29.37) | |
| 2 | 572 (5.77) | 740 (5.12) | |
| 3 ≤ | 221 (2.23) | 171(1.18) |
Values are presented as mean ± SD or number (%). GA: general anesthesia, RA: regional anesthesia, DM: diabetes mellitus.
Perioperative Data from Patients That Underwent Total Hip Replacement Arthroplasty.
| Group GA (n = 9,921) | Group RA (n = 14,458) | P value | |
|---|---|---|---|
| Diagnosis | < 0.001 | ||
| Necrosis (M87) | 4,634 (46.71) | 7,787 (53.86) | |
| Unspecified hip arthropathy (M16) | 1,741 (17.55) | 2,618 (18.11) | |
| Femur fracture (S72) | 900 (9.07) | 1,439 (9.95) | |
| Other arthropathy (M19) | 274 (2.76) | 303 (2.10) | |
| Other arthritis (M13) | 219 (2.21) | 418 (2.89) | |
| etc. | 2,153 (21.70) | 1,893 (13.09) | |
| Hospital stay (days) | 17.88 ± 11.96 | 18.10 ± 11.10 | < 0.001 |
| Cost (won) | 651.93 (564.35–730.34) | 617.25 (545.26–709.31) | < 0.001 |
| Patient charges (won) | 128.65 (68.40–149.86) | 123.61 (75.71–144.95) | < 0.001 |
| Insurance (won) | 526.87 (452.42–600.83) | 494.69 (436.03–580.40) | < 0.001 |
| Delirium | 142 (1.43) | 209 (0.86) | 0.927 |
| Mortality rate during hospitalization | 20 (0.20) | 36 (0.25) | 0.448 |
Values are presented as mean ± SD or number (%). GA: general anesthesia, RA: regional anesthesia, DM: diabetes mellitus.
Logistic Regression Analysis of Patients That Underwent Total Hip Replacement Arthroplasty.
| Univariate | P value | Multivariate | P value | |||||
|---|---|---|---|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||||||
| Sex | 0.788 | 0.631 | 0.985 | 0.037 | 0.779 | 0.622 | 0.975 | 0.029 |
| Anesthetic method | 0.990 | 0.799 | 1.227 | 0.927 | ||||
| Age | 1.000 | 0.991 | 1.009 | 0.989 | ||||
| Hypertension | 0.935 | 0.704 | 1.242 | 0.642 | ||||
| DM | 0.969 | 0.690 | 1.360 | 0.856 | ||||
| Cardiac disease | 0.881 | 0.523 | 1.484 | 0.633 | ||||
| Myocardial infarction | 1.955 | 0.862 | 4.430 | 0.108 | 1.955 | 0.862 | 4.434 | 0.109 |
| Chronic pulmonary disease | 0.392 | 0.122 | 1.193 | 0.097 | 0.381 | 0.122 | 1.193 | 0.097 |
| Diagnosis for surgery | 0.996 | 0.906 | 1.096 | 0.940 | ||||
| Dementia | < 0.001 | < 0.001 | > 999.9 | 0.968 | ||||
| Parkinson’s disease | < 0.001 | < 0.001 | > 999.9 | 0.976 | ||||
| Mental and behavioral disorder (mood) | 1.180 | 0.523 | 2.663 | 0.691 | ||||
| Chronic kidney disease | 0.734 | 0.181 | 1.932 | 0.596 | ||||
| Peripheral vascular disease | 0.481 | 0.179 | 1.292 | 0.146 | 0.478 | 0.178 | 1.285 | 0.144 |
| Mild liver disease | 0.771 | 0.557 | 1.066 | 0.115 | 0.739 | 0.533 | 1.024 | 0.069 |
| Acquired immune deficiency syndrome | 5.59 | 1.718 | 18.220 | 0.004 | 5.001 | 1.532 | 16.318 | 0.008 |
| Charlson comorbidity index | 1.013 | 0.887 | 1.158 | 0.845 | ||||
Values are presented as mean ± SD or number (%). DM: diabetes mellitus.
P < 0.15 for univariate-crude data
P < 0.05 for multivariate-crude data.